Spirair

Founded: 2020 • Age: 6 yrs
Medical devices for nasal septal deviation treatment are developed.
Annual revenue - Latest available
Total funding $12.8M 1 rounds
Employees - Tracked headcount
Investors - Known backers
Products 1 Services tracked
Competitors 8 Brand Intelligence

About Spirair

Spirair is a company founded in 2020. Spirair has raised $12.76 million across 1 funding round. Spirair offers products and services including SeptAlign. Spirair operates in a competitive market with competitors including Navage, Arrinex, Chordate, ENTpro and NeilMed, among others.

  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $12.76 M (USD)

    in 1 rounds

  • Latest Funding Round
    $12.76 M (USD), Series B

    Jul 28, 2025

  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Spirair

Spirair offers a comprehensive portfolio of products and services, including SeptAlign.

Product name locked
Category locked
Primary

Bioabsorbable device for mechanical correction of nasal septal deviations.

Funding Insights of Spirair

Spirair has successfully raised a total of $12.76M through 1 strategic funding round. The most recent funding activity was a Series B round of $12.76 million completed in July 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investments & Acquisitions by Spirair

Investments
Premium access

Investment portfolio details for Spirair

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Spirair

Premium access

Detailed financials for Spirair

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Spirair Comparisons

Spirair Primary company
Description
Medical devices for nasal septal deviation treatment are dev...
Location
-
Founded Year
2020
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Spirair

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Spirair

Spirair operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Navage, Arrinex, Chordate, ENTpro and NeilMed, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Nasal irrigator that uses suction
Locked Locked Locked
Hand-held disposable cryotherapy devices for ENT procedures are developed.
Locked Locked Locked
Develops and markets CE-marked devices for migraine and rhinitis treatment.
Locked Locked Locked
Simple medical devices for nasal cleaning and reduction of snoring
Locked Locked Locked
Manufactures nasal irrigation systems for sinus and allergy relief worldwide.
Locked Locked Locked
Products for comfortable breathing and sleep aids are developed.
Premium access

Detailed competitors of Spirair

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Spirair

Premium access

Complete news archive for Spirair

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Spirair

Spirair was founded in 2020 and raised its 1st funding round 5 years after it was founded.

Spirair is a funded company, having raised a total of $12.76M across 1 funding round to date.

Spirair was founded in 2020 as a developer of medical devices focused on nasal septal deviation. Minimally invasive solutions are provided to address nasal obstruction, with applications in ear, nose, and throat conditions as well as sleep disorders. Operations center on innovation within the medical device sector, targeting treatments that support respiratory health without extensive surgical intervention.

Spirair's top competitors include Navage, Arrinex and Nasal Medical.

Spirair offers SeptAlign.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available